These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24401662)

  • 21. The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy.
    Sandal T; Laborie LB; Brusgaard K; Eide SA; Christesen HB; Søvik O; Njølstad PR; Molven A
    Clin Genet; 2009 May; 75(5):440-8. PubMed ID: 19475716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update of variants identified in the pancreatic β-cell K
    De Franco E; Saint-Martin C; Brusgaard K; Knight Johnson AE; Aguilar-Bryan L; Bowman P; Arnoux JB; Larsen AR; Sanyoura M; Greeley SAW; Calzada-León R; Harman B; Houghton JAL; Nishimura-Meguro E; Laver TW; Ellard S; Del Gaudio D; Christesen HT; Bellanné-Chantelot C; Flanagan SE
    Hum Mutat; 2020 May; 41(5):884-905. PubMed ID: 32027066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism.
    Banerjee I; Skae M; Flanagan SE; Rigby L; Patel L; Didi M; Blair J; Ehtisham S; Ellard S; Cosgrove KE; Dunne MJ; Clayton PE
    Eur J Endocrinol; 2011 May; 164(5):733-40. PubMed ID: 21378087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms of neonatal hyperinsulinism.
    Giurgea I; Bellanné-Chantelot C; Ribeiro M; Hubert L; Sempoux C; Robert JJ; Blankenstein O; Hussain K; Brunelle F; Nihoul-Fékété C; Rahier J; Jaubert F; de Lonlay P
    Horm Res; 2006; 66(6):289-96. PubMed ID: 17003566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.
    Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C
    Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and clinical features of K
    Hashimoto Y; Dateki S; Hirose M; Satomura K; Sawada H; Mizuno H; Sugihara S; Maruyama K; Urakami T; Sugawara H; Shirai K; Yorifuji T
    Pediatr Diabetes; 2017 Nov; 18(7):532-539. PubMed ID: 27681997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism: clinical and functional characterization of two novel ABCC8 mutations.
    Faletra F; Snider K; Shyng SL; Bruno I; Athanasakis E; Gasparini P; Dionisi-Vici C; Ventura A; Zhou Q; Stanley CA; Burlina A
    Gene; 2013 Mar; 516(1):122-5. PubMed ID: 23266803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics and phenotype-genotype analysis in Turkish patients with congenital hyperinsulinism; predominance of recessive KATP channel mutations.
    Demirbilek H; Arya VB; Ozbek MN; Akinci A; Dogan M; Demirel F; Houghton J; Kaba S; Guzel F; Baran RT; Unal S; Tekkes S; Flanagan SE; Ellard S; Hussain K
    Eur J Endocrinol; 2014 Jun; 170(6):885-92. PubMed ID: 24686051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods for Characterizing Disease-Associated ATP-Sensitive Potassium Channel Mutations.
    Kandasamy B; Shyng SL
    Methods Mol Biol; 2018; 1684():85-104. PubMed ID: 29058186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening.
    Maiorana A; Barbetti F; Boiani A; Rufini V; Pizzoferro M; Francalanci P; Faletra F; Nichols CG; Grimaldi C; de Ville de Goyet J; Rahier J; Henquin JC; Dionisi-Vici C
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):679-88. PubMed ID: 24383515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype-phenotype associations in patients with severe hyperinsulinism of infancy.
    Greer RM; Shah J; Jeske YW; Brown D; Walker RM; Cowley D; Bowling FG; Liaskou D; Harris M; Thomsett MJ; Choong C; Bell JR; Jack MM; Cotterill AM
    Pediatr Dev Pathol; 2007; 10(1):25-34. PubMed ID: 17378627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital hyperinsulinism due to a compound heterozygous ABCC8 mutation with spontaneous resolution at eight weeks.
    Kumaran A; Kapoor RR; Flanagan SE; Ellard S; Hussain K
    Horm Res Paediatr; 2010; 73(4):287-92. PubMed ID: 20215776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ABCC8 mutation allele frequency in the Ashkenazi Jewish population and risk of focal hyperinsulinemic hypoglycemia.
    Glaser B; Blech I; Krakinovsky Y; Ekstein J; Gillis D; Mazor-Aronovitch K; Landau H; Abeliovich D
    Genet Med; 2011 Oct; 13(10):891-4. PubMed ID: 21716120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms of congenital hyperinsulinism due to autosomal dominant mutations in ABCC8.
    Nessa A; Aziz QH; Thomas AM; Harmer SC; Tinker A; Hussain K
    Hum Mol Genet; 2015 Sep; 24(18):5142-53. PubMed ID: 26092864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11.
    Hewat TI; Yau D; Jerome JCS; Laver TW; Houghton JAL; Shields BM; Flanagan SE; Patel KA
    Eur J Endocrinol; 2021 Oct; 185(6):813-818. PubMed ID: 34633981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life.
    Vedovato N; Salguero MV; Greeley SAW; Yu CH; Philipson LH; Ashcroft FM
    Diabetologia; 2024 May; 67(5):940-951. PubMed ID: 38366195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions.
    Henquin JC; Nenquin M; Sempoux C; Guiot Y; Bellanné-Chantelot C; Otonkoski T; de Lonlay P; Nihoul-Fékété C; Rahier J
    J Clin Invest; 2011 Oct; 121(10):3932-42. PubMed ID: 21968111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial ABCC8 gene deletion mutations causing diazoxide-unresponsive hyperinsulinaemic hypoglycaemia.
    Flanagan S; Damhuis A; Banerjee I; Rokicki D; Jefferies C; Kapoor R; Hussain K; Ellard S
    Pediatr Diabetes; 2012 May; 13(3):285-9. PubMed ID: 21978130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sirolimus in the treatment of three infants with diffuse congenital hyperinsulinism.
    Al-Balwi R; Al-Atawi M; Al-Otaibi A; Babiker O; Al-Mutair A
    J Pediatr Endocrinol Metab; 2017 Aug; 30(9):1013-1017. PubMed ID: 28787272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotype and phenotype analysis of a cohort of patients with congenital hyperinsulinism based on DOPA-PET CT scanning.
    Ni J; Ge J; Zhang M; Hussain K; Guan Y; Cheng R; Xi L; Zheng Z; Ren S; Luo F
    Eur J Pediatr; 2019 Aug; 178(8):1161-1169. PubMed ID: 31218401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.